Natco Pharma Limited | NATCOPHARM | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 2,795 | 660 | 2,835 | 2,061 | 5,463 |
Short-term investment |
| 1,487 | 287 | 1,443 | 2,037 | 3,050 |
Accounts receivables |
| 5,062 | 5,513 | 4,129 | 6,206 | 8,561 |
Inventories |
| 5,290 | 5,580 | 7,982 | 7,620 | 7,429 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 8,838 | 11,216 | 6,984 | 6,943 | 5,500 |
Total current assets |
| 23,472 | 23,256 | 23,373 | 24,867 | 30,003 |
Gross property plant... |
| 12,185 | 15,756 | 20,138 | 21,789 | 22,391 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 12,185 | 15,756 | 20,138 | 21,789 | 22,391 |
Work in Progress |
| 6,376 | 5,180 | 2,234 | 1,295 | 643 |
Miscellaneous Investment |
| 384 | 997 | 1,795 | 1,237 | 1,043 |
Deferred income taxes |
| 0 | 0 | 0 | 105 | 345 |
Intangible assets |
| 87 | 88 | 94 | 822 | 1,326 |
Goodwill |
| 0 | 0 | 0 | 507 | 552 |
Other long-term assets |
| 527 | 601 | 285 | 469 | 271 |
Total non-current assets |
| 19,559 | 22,622 | 24,546 | 26,224 | 26,571 |
Total assets |
| 43,031 | 45,878 | 47,919 | 51,091 | 56,574 |
Short-term debt |
| 3,863 | 3,150 | 2,667 | 4,040 | 1,650 |
Accounts Payable... |
| 2,170 | 2,554 | 1,462 | 1,618 | 2,638 |
Provisions |
| 90 | 105 | 128 | 170 | 169 |
Taxes Payable |
| 66 | 85 | 13 | 9 | 101 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 35 | 6 |
Other current liabilities |
| 1,098 | 959 | 986 | 1,232 | 2,267 |
Total current liabilities |
| 7,287 | 6,853 | 5,256 | 7,104 | 6,831 |
Long-term debt |
| 0 | 9 | 9 | 0 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 116 | 259 | 413 | 301 | 124 |
Provisions |
| 710 | 902 | 996 | 957 | 853 |
Capital Leases |
| 0 | 0 | 0 | 80 | 11 |
Other longterm liabilities |
| 8 | 8 | 11 | 13 | 17 |
Total non-current liabilities |
| 834 | 1,178 | 1,429 | 1,351 | 1,005 |
Total liabilities |
| 8,121 | 8,031 | 6,685 | 8,455 | 7,836 |
Share Capital |
| 365 | 364 | 365 | 365 | 365 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 34,525 | 37,371 | 40,851 | 42,271 | 48,373 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 20 | 112 | 18 | 0 | 0 |
Total Equity |
| 34,910 | 37,847 | 41,234 | 42,636 | 48,738 |
Total Liabilities and Equity |
| 43,031 | 45,878 | 47,919 | 51,091 | 56,574 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |